Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.

[1]  R. Califf,et al.  N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy , 2003, Circulation.

[2]  David A Morrow,et al.  Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy , 2003, Circulation.

[3]  M. Sabatine,et al.  Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. , 2003, Journal of the American College of Cardiology.

[4]  J. Herlitz,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes , 2002, Circulation.

[5]  D. Morrow,et al.  Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes: Ready for Clinical Application? , 2002, Circulation.

[6]  B. Lindahl,et al.  N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. , 2002, Journal of the American College of Cardiology.

[7]  J. Hollander,et al.  B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study , 2002, Circulation.

[8]  M. Cowie,et al.  BNP and congestive heart failure. , 2002, Progress in cardiovascular diseases.

[9]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[10]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[11]  U. Dohrmann,et al.  Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human Myocardium: Influence of Angiotensin II and Diastolic Fiber Length , 2000, Circulation.

[12]  Margarida Pereira,et al.  Clinical Significance of Brain Natriuretic Peptide in Patients with Postmyocardial Infarction , 2000, Clinical cardiology.

[13]  I. Squire,et al.  Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina , 2000, Heart.

[14]  M. Ohyanagi,et al.  Transient increase in plasma brain (b‐type) natriuretic peptide after percutaneous transluminal coronary angioplasty , 2000, Clinical cardiology.

[15]  D. Kremastinos,et al.  Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty , 2000, Clinical cardiology.

[16]  K. Kangawa,et al.  Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction. , 1998, International journal of cardiology.

[17]  K. Kangawa,et al.  Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. , 1998, American heart journal.

[18]  H Sumida,et al.  Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. , 1996, American heart journal.

[19]  N. Arakawa,et al.  Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[20]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[21]  M. Hamada,et al.  Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. , 1995, Clinical science.

[22]  N. Arakawa,et al.  Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. , 1994, Cardiology.

[23]  K. Nakao,et al.  Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction , 1993, Circulation.

[24]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[25]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.